Currently out of the existing stock ratings of Difei Yang, 175 are a BUY (87.94%), 22 are a HOLD (11.06%), 2 are a SELL (1.01%).

Difei Yang

Work Performance Price Targets & Ratings Chart

Analyst Difei Yang works at MIZUHO with a stock forecast success ratio of 44.24% fulfilled within 210.24 days on average. Previously, Difei Yang worked at AEGIS, BREAN.

Difei Yang’s has documented 405 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SRPT, Sarepta Therapeutics at 24-Jun-2022.

Wall Street Analyst Difei Yang

Analyst best performing recommendations are on RLYP (RELYPSA).
The best stock recommendation documented was for RLYP (RELYPSA) at 7/18/2016. The price target of $26 was fulfilled within 3 days with a profit of $5.75 (28.4%) receiving and performance score of 94.65.

Average potential price target upside

AERI Aerie Pharmaceuticals . AKBA Akebia Ther BLUE Bluebird bio CNCE Concert Pharmaceuticals FGEN FibroGen FRLN Freeline Therapeutics Holdings Plc HZNP Horizon Pharma PLC MNTA Momenta Pharmaceuticals NKTR Nektar Therapeutics NVCR Novocure Ltd RLYP Relypsa RVNC Revance The SELB Selecta Biosciences SRPT Sarepta Therapeutics XERS Xeris Pharmaceuticals ZGNX Zogenix MGTA Magenta Therapeutics ONCE Spark Therapeutics PTX Pernix Therapeutics Holdings AVRO AVROBIO HRTX Heron Therapeuti ALDR Alder BioPharmaceuticals BOLD Audentes Therapeutics EOLS Evolus ABEO Abeona Therapeutics AKAO Achaogen MRNS Marinus Pharmaceuticals VNDA Vanda Pharmaceuticals QURE Uniqure NV

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

14

$-1.25 (-8.20%)

13

1 years 5 months 30 days ago

1/6 (16.67%)

$-1.07 (-7.10%)

176

Buy

13

$-2.25 (-14.75%)

1 years 6 months 4 days ago

0/2 (0%)

$-2.18 (-14.36%)

Hold

20

1 years 6 months 4 days ago

0/1 (0%)

$14.21 (245.42%)

Buy

15.25

27

1 years 6 months 5 days ago

8/13 (61.54%)

$0.09 (0.59%)

136

Hold

15.25

30

1 years 6 months 5 days ago

1/3 (33.33%)

$0.09 (0.59%)

48

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Difei Yang?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?